Authors:
MOHAMMAD RM
KATATO K
ALMATCHY VP
WALL N
LIU KZ
SCHULTZ CP
MANTSCH HH
VARTERASIAN M
ALKATIB AM
Citation: Rm. Mohammad et al., SEQUENTIAL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA WITH BRYOSTATIN-1 FOLLOWED BY 2-CHLORODEOXYADENOSINE - PRECLINICAL STUDIES, Clinical cancer research, 4(2), 1998, pp. 445-453
Authors:
MOHAMMAD RM
KATATO K
ALMATCHY VP
WALL N
LIU KZ
SCHULTZ CP
MANTSCH HH
VARTERASIAN M
ALKATIB AM
Citation: Rm. Mohammad et al., SEQUENTIAL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA WITH BRYOSTATIN-1 FOLLOWED BY 2-CHLORODEOXYADENOSINE - PRECLINICAL STUDIES, Clinical cancer research, 4(2), 1998, pp. 445-453
Authors:
MOHAMMAD RM
PETTIT GR
ALMATCHY VP
WALL N
VARTERASIAN M
ALKATIB A
Citation: Rm. Mohammad et al., SYNERGISTIC INTERACTION OF SELECTED MARINE ANIMAL ANTICANCER DRUGS AGAINST HUMAN DIFFUSE LARGE-CELL LYMPHOMA, Anti-cancer drugs, 9(2), 1998, pp. 149-156
Citation: M. Varterasian et al., THE HETEROGENEITY OF LEUKEMIA OCCURRING AFTER TREATMENT FOR SARCOMA, American journal of clinical oncology, 20(6), 1997, pp. 585-586
Authors:
VARTERASIAN M
JANAKIRAMAN N
KARANES C
ABELLA E
UBERTI J
DRAGOVIC J
RAMAN SBK
ALKATIB A
DU W
SILVER SM
ADAMS PT
SENSENBRENNER L
RATANATHARATHORN V
Citation: M. Varterasian et al., TRANSPLANTATION IN PATIENTS WITH MULTIPLE-MYELOMA - A MULTICENTER COMPARATIVE-ANALYSIS OF PERIPHERAL-BLOOD STEM-CELL AND ALLOGENEIC TRANSPLANT, American journal of clinical oncology, 20(5), 1997, pp. 462-466
Citation: K. Katato et al., SECONDARY ACUTE MYELOGENOUS LEUKEMIA FOLLOWING TREATMENT WITH ORAL ETOPOSIDE, American journal of hematology, 53(1), 1996, pp. 54-55
Citation: Y. Arabi et M. Varterasian, ACQUIRED CENTRAL DIABETES-INSIPIDUS COMPLICATING ACUTE MEGAKARYOCYTICLEUKEMIA, American journal of hematology, 52(3), 1996, pp. 241-241
Authors:
ALKATIB A
KATATO K
VARTERASIAN M
MOHAMED AN
DUGAN M
MOHAMMAD RM
Citation: A. Alkatib et al., ANTITUMOR-ACTIVITY OF BRYOSTATIN-1 AGAINST CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) IN A SCID MOUSE XENOGRAFT MODEL, Experimental hematology, 24(9), 1996, pp. 693-693
Authors:
MOHAMMAD RM
DUGAN MC
VARTERASIAN M
PETTIT GR
ALKATIB A
Citation: Rm. Mohammad et al., PRECLINICAL EVALUATION OF BRYOSTATIN-1, DOLASTATIN BRYOSTATIN-10 AND THEIR COMBINATION AGAINST DIFFUSE LARGE-CELL LYMPHOMA XENOGRAFT, Blood, 88(10), 1996, pp. 3497-3497
Authors:
MOHAMED AN
KOPPITCH F
VARTERASIAN M
KARANES C
YAO KL
SARKAR FH
Citation: An. Mohamed et al., BCR ABL FUSION LOCATED ON CHROMOSOME-9 IN CHRONIC MYELOID-LEUKEMIA WITH A MASKED PH CHROMOSOME/, Genes, chromosomes & cancer, 13(2), 1995, pp. 133-137
Authors:
VARTERASIAN M
RATANATHARATHORN V
UBERTI JP
KARANES C
ABELLA E
MOMIN F
KASTENSPORTES C
ALKATIB A
LUM L
HEILBRUN LK
SENSENBRENNER LL
Citation: M. Varterasian et al., CLINICAL COURSE AND OUTCOME OF PATIENTS WITH HODGKINS-DISEASE WHO PROGRESS AFTER AUTOLOGOUS TRANSPLANTATION, Leukemia & lymphoma, 20(1-2), 1995, pp. 59-65
Authors:
VARTERASIAN M
RATANATHARATHORN V
KARANES C
UBERTI J
MOMIN F
ABELLA E
LUM LG
HEILBRUN LK
SENSENBRENNER LL
Citation: M. Varterasian et al., BONE-MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA - THE WAYNE-STATE EXPERIENCE, Bone marrow transplantation, 15(2), 1995, pp. 328-329
Authors:
SMITH MR
COMPEAN R
VARTERASIAN M
LATTIN P
EILENDER D
HARMS P
ALKATIB AM
Citation: Mr. Smith et al., COMBINED-MODALITY THERAPY WITH MOPP MITOXANTRONE-BV-DISEASE( INVOLVEDFIELD RADIOTHERAPY FOR EARLY CLINICAL STAGE HODGKINS), Blood, 84(10), 1994, pp. 10000161-10000161
Authors:
VARTERASIAN M
LIPKOWITZ S
KARSCHMIZRACHI I
PATERSON B
KIRSCH I
Citation: M. Varterasian et al., 2 NEW DROSOPHILA GENES RELATED TO HUMAN HEMATOPOIETIC AND NEUROGENIC TRANSCRIPTION FACTORS, Cell growth & differentiation, 4(11), 1993, pp. 885-889